Skip to main content
. Author manuscript; available in PMC: 2015 Jan 13.
Published in final edited form as: Invest New Drugs. 2014 Mar 27;32(4):739–745. doi: 10.1007/s10637-014-0083-8

Table 3.

Survival Measures

Outcome Total Patients (N = 18)


Overall Survival
    Alive at 6 Months N (%) 5 (28)
Exact 95% CI (10, 54)
    Months-to-Death Median (95% CI) 4.1 (2.7, 5.8)
Mean (95% CI) 5.4 (3.5, 7.3)
Progression-Free Survival
    Non-Progression at 3 Months N (%) 4 (22)
Exact 95% CI (6, 48)
    Months-to-Progression Median (95% CI) 1.5 (1.3, 1.6)
Mean (95% CI) 1.9 (1.3, 2.5)